Most Popular - Shares of Amarin, plc (NASDAQ:AMRN) were highly volatile in early afternoon trading Thursday as an article written in the P&T Journal, published on a National … Continue Reading
Read NowLong Ideas - In an 8K released on Wednesday morning, Amarin Corp. (NASDAQ:AMRN) revealed that the FDA still has not made a decision regarding Vascepa’s New Chemical Entity … Continue Reading
Read NowLong Ideas - Following news that Elan’s (NASDAQ:ELN) developmental Alzheimer’s treatment, bapineuzumab, failed a Phase III trial in August and was subsequently discontinued, PropThink advised a position in … Continue Reading
Read NowLong Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) announced prescription trend data this morning for its primary revenue driver, H.P. Acthar Gel (Acthar), and the news is positive, sending the … Continue Reading
Read NowMost Popular - We continued to add to our Interview collection, posting discussions this past week with the CEO’s of both AdventRx Pharmaceuticals and ARIAD Pharmaceuticals. Our final … Continue Reading
Read NowMost Popular - By David Moskowitz Peregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results … Continue Reading
Read NowLong Ideas - Exelixis (NASDAQ:EXEL) Thursday is retracing some of its losses from the beginning of the week and is up 10% from yesterday’s close, to $5.00, due … Continue Reading
Read Now